Member Info for Rockefellow

A reply to me too!

$1bn pa plus.fast tracked.

Seaport float will be a major catalyst..

Great summary.New stuff to come in too.There is almost no biotech sector in the UK.Im sure Puretech is inundated with opportunities.

Now has own website.

https://www.galloponcology.com/

There is no way Puretech will want to be taken over.I would like to see my medium term goal of £10bn cap achieved.

On the last fundraise the implied value of the 35pc was $255m.plus 3 to 5pc royalties

Puretech still owns 4.2pc

https://www.vedantabio.com/press-release/vedanta-biosciences-showcases-innovative-work-on-its-microbiome-based-therapeutics-at-the-european-society-of-clinical-microbiology-and-infectious-diseases-escmid-2026-global-congress/

Kailera raised upsized $625m ..went to 60pc premium.Seaport will be red hot!

Royalty Pharma deal https://news.puretechhealth.com/news-releases/news-release-details/prtc-gets-500m-rprx-karxt-royalty

Cobenfy is on the market selling.Pure has potent royalties of around $400m still to come.

🚀🚀🚀🚀🚀🚀

Still 1.1pc

Puretech is working on new projects…so I think my target is perfectly possible.

Is my prediction

Karuna holders made billions and this will be the first time for many to participate so I expect it to be upsized to $175m ish heavily oversubscribed.

20 bagger..

Cash is currently around $265m

Karuna trebled in six months after IPO.This offering will be expanded and massively overscribed.

Finals at the end of the month🚀🚀🚀😱